168 related articles for article (PubMed ID: 30716657)
1. Intercellular adhesion molecule-1 (ICAM-1) associates with 24-hour ambulatory blood pressure variability in type 2 diabetes and controls.
Ciobanu DM; Mircea PA; Bala C; Rusu A; Vesa Ş; Roman G
Cytokine; 2019 Apr; 116():134-138. PubMed ID: 30716657
[TBL] [Abstract][Full Text] [Related]
2. Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation.
Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Rixe J; Hamm C; Nef H
Hypertension; 2014 May; 63(5):984-90. PubMed ID: 24470464
[TBL] [Abstract][Full Text] [Related]
3. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension.
Boulbou MS; Koukoulis GN; Makri ED; Petinaki EA; Gourgoulianis KI; Germenis AE
Int J Cardiol; 2005 Jan; 98(1):39-44. PubMed ID: 15676164
[TBL] [Abstract][Full Text] [Related]
4. Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes.
Liu JJ; Yeoh LY; Sum CF; Tavintharan S; Ng XW; Liu S; Lee SB; Tang WE; Lim SC;
J Diabetes Complications; 2015 Jul; 29(5):707-12. PubMed ID: 25857767
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of ICAM-1 and circulating endothelial cells are elevated in unstable types 1 and 2 diabetes.
El Amine M; Sohawon S; Lagneau L; Gaham N; Noordally S
Endocr Regul; 2010 Jan; 44(1):17-24. PubMed ID: 20151764
[TBL] [Abstract][Full Text] [Related]
6. Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia.
Turhan H; Erbay AR; Yasar AS; Aksoy Y; Bicer A; Yetkin G; Yetkin E
Coron Artery Dis; 2005 Feb; 16(1):45-50. PubMed ID: 15654200
[TBL] [Abstract][Full Text] [Related]
7. Study of the association of adrenomedullin and basic-fibroblast growth factors with the peripheral arterial blood flow and endothelial dysfunction biomarkers in type 2 diabetic patients with peripheral vascular insufficiency.
Alrouq FA; Al-Masri AA; Al-Dokhi LM; Alregaiey KA; Bayoumy NM; Zakareia FA
J Biomed Sci; 2014 Oct; 21(1):94. PubMed ID: 25287126
[TBL] [Abstract][Full Text] [Related]
8. Role of adhesion molecule expression and soluble fractions in hepatic resection.
Shimada M; Kajiyama K; Hasegawa H; Gion T; Ikeda Y; Shirabe K; Takenaka K; Sugimachi K
J Am Coll Surg; 1998 May; 186(5):534-41. PubMed ID: 9583693
[TBL] [Abstract][Full Text] [Related]
9. Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.
Bruno CM; Valenti M; Bertino G; Ardiri A; Bruno F; Cunsolo M; Pulvirenti D; Neri S
Minerva Med; 2008 Feb; 99(1):1-5. PubMed ID: 18299691
[TBL] [Abstract][Full Text] [Related]
10. Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus.
Rizzoni D; Muiesan ML; Porteri E; Castellano M; Salvetti M; Monteduro C; De Ciuceis C; Boari G; Valentini U; Cimino A; Sleiman I; Agabiti-Rosei E
J Hum Hypertens; 2003 Jul; 17(7):463-70. PubMed ID: 12821953
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous transluminal mitral valvuloplasty reduces circulating vascular cell adhesion molecule-1 in rheumatic mitral stenosis.
Chen MC; Chang HW; Juang SS; Yip HK; Wu CJ; Yu TH; Cheng CI
Chest; 2004 Apr; 125(4):1213-7. PubMed ID: 15078727
[TBL] [Abstract][Full Text] [Related]
12. Association between the levels of circulating adhesion molecules and biopterins in type-2 diabetic normotensive patients adhesion molecules and biopterins.
Rubio-Guerra AF; Vargas-Robles H; Del Valle-Mondragon L; Lozano-Nuevo JJ; Escalante-Acosta BA
Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):243-6. PubMed ID: 22497223
[TBL] [Abstract][Full Text] [Related]
13. Circulating intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin in patients with type 2 diabetes mellitus.
Kado S; Nagata N
Diabetes Res Clin Pract; 1999 Nov; 46(2):143-8. PubMed ID: 10724093
[TBL] [Abstract][Full Text] [Related]
14. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.
Papagianni A; Kalovoulos M; Kirmizis D; Vainas A; Belechri AM; Alexopoulos E; Memmos D
Nephrol Dial Transplant; 2003 Jan; 18(1):113-9. PubMed ID: 12480968
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
Meigs JB; Hu FB; Rifai N; Manson JE
JAMA; 2004 Apr; 291(16):1978-86. PubMed ID: 15113816
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.
Song Y; Manson JE; Tinker L; Rifai N; Cook NR; Hu FB; Hotamisligil GS; Ridker PM; Rodriguez BL; Margolis KL; Oberman A; Liu S
Diabetes; 2007 Jul; 56(7):1898-904. PubMed ID: 17389327
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestations.
Thakkar V; Patterson KA; Stevens W; Wilson M; Roddy J; Sahhar J; Proudman S; Hissaria P; Nikpour M
Clin Rheumatol; 2018 Jun; 37(6):1563-1571. PubMed ID: 29687288
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
Papayianni A; Alexopoulos E; Giamalis P; Gionanlis L; Belechri AM; Koukoudis P; Memmos D
Nephrol Dial Transplant; 2002 Mar; 17(3):435-41. PubMed ID: 11865089
[TBL] [Abstract][Full Text] [Related]
19. Effect of uncontrolled hyperglycemia on levels of adhesion molecules in patients with diabetes mellitus type 2.
Ruszkowska-Ciastek B; Sokup A; Wernik T; Ruprecht Z; Góralczyk B; Góralczyk K; Gadomska G; Rość D
J Zhejiang Univ Sci B; 2015 May; 16(5):355-61. PubMed ID: 25990052
[TBL] [Abstract][Full Text] [Related]
20. Correlation between circulating adhesion molecules and resistin levels in hypertensive type-2 diabetic patients.
Lozano-Nuevo JJ; Estrada-Garcia T; Vargas-Robles H; Escalante-Acosta BA; Rubio-Guerra AF
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):27-31. PubMed ID: 21184654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
